NASDAQ Biotechnology Index

(redirected from NASDAQ Biotech Index)

NASDAQ Biotechnology Index

An index tracking pharmaceutical, biological research and similar companies whose shares trade on NASDAQ. It is weighted under a modified market capitalization scheme; the securities that compose it are updated semi-annually.
References in periodicals archive ?
Biotech has been the best-performing niche in healthcare in 2017, with the iShares Nasdaq Biotech index up 40 per cent year-to-date.
Here are sector strategies, global equities risk in Q4
By comparison, the Nasdaq Biotech Index (IBB) has fallen around 25% over that same time frame.
Advisors: Be Careful What Funds You Own
The Nasdaq Biotech Index saw five pullbacks of more than 6.
Biotech resilience put to test as stocks fall into bear market
The Nasdaq biotech index gave close to 30 per cent returns compared to the MSCI world index, which gave close to 5 per cent.
What investors should look for in 2015?
Biotech stocks, as measured by the Nasdaq Biotech Index (NBI), have risen 50% over the past year, in part due to a spate of mergers and acquisitions as big pharmaceutical companies seek to bolster their pipelines of experimental drugs.
Biogen Reaches deal with Icahn; avoids proxy fight
The Biotechnology Industry Organization reports that the Nasdaq biotech index surged 46% in 2003, helping biotech companies amass $16.
Instrument sales strong despite rising business costs
After the March 13 announcement to that effect by President Bill Clinton and British Prime Minister Tony Blair, the NASDAQ Biotech Index lost one-eighth of its value in two days.
What biotech needs to grow
Biotechnology: Between 1992 and 1995, the Nasdaq biotech index fell by 70%.
Industry Watch
Financial browser ?
Full browser ?